Ссылки

1.Virapen J. Side Effects: death. College Station: Virtualbookworm.com Publishing; 2010.

2.Angell M. The Truth about the Drug Companies: how they deceive us and what to do about it. New York: Random House; 2004.

3.Abramson J. Overdsed America: the broken promise of American medicine. New York: HarperCollins; 2004.

4.Wilmshurst P. Academia and industry. Lancet. 2000; 356: 338–44.

5.Steinman M. A., Bero L. A., Chren M. M., et al. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006; 145: 284–93.

6.Braithwaite J. Corporate Crime in the Pharmaceutical Industry. London: Routledge & Kegan Paul; 1984.

7.Transparency International. Global Corruption Report 2006. Available online at: www. transparency.org/publications/gcr (accessed 8 February 2008).

8.House of Commons Health Committee. The Infl uence of the Pharmaceutical Industry. Fourth Report of Session 2004–05. 2005. Available online at: www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf (accessed 26 April 2005).

9.Chren M. M., Landefeld C. S. Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994; 271: 684–9.

10.Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373–80.

11.Grill M. Kranke Geschäfte: wie die Pharmaindustrie uns manipuliert. Hamburg: Rowohlt Verlag; 2007.

12.Mundy A. Dispensing with the Truth. New York: St. Martin’s Press;

2001.

13.Avorn J. Powerful Medicines: the benefits, risks, and costs of prescription drugs. New York: Vintage Books; 2005.

14.Kassirer J. P. On the Take: how medicine’s complicity with big business can endanger your health. Oxford: Oxford University Press; 2005.

15.Gale E. A. Conflicts of interest in guideline panel members. BMJ. 2011; 343: d5728.

16.Boseley S. Drug firms using backdoor tactics to boost sales, report reveals. The Guardian. 2011 Sept 23.

17.Lenzer J. Whistleblower removed from job for talking to the press. BMJ. 2004; 328: 1153.

18.Elliott C. The drug pushers. The Atlantic Monthly. 2006 April.

19.Palo J. Why did my colleagues turn to crime? BMJ. 2004; 328:

1083.

20.Applegate W. B., Furberg C. D., Byington R. P., et al. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). JAMA. 1997; 277: 297.

21.Harris G. As doctors write prescriptions, drug company writes a check. New York Times. 2004 June 27.

22.Elkjær B., Rebouh D., Jensen J., et al. [See if your doctor is in industry’s pocket]. Ekstra Bladet. 2010 June 24.

23.Editorial. [The greedy doctors]. Ekstra Bladet. 2010 June 24.